COVID-19 vaccine candidates in India:Three vaccine candidates are at different stages of clinical trials in the country.
Developed by Bharat Biotech International Limited along with Indian Council of Medical Research and National Institute of Virology, Covaxin was India's first indigenous vaccine candidate against the novel COVID-19.
Covaxin is currently in Phase II human trials in the country."There had been 'no side effects' in the phase I trial of Covaxin," Dr E Venkata Rao, principal investigator of the trial at Institute of Medical Sciences and SUM Hospital, faculty of medical sciences, said.ZyCoV-D, developed by Zydus Cadila began its phase II clinical trials from August 6. "The company reports that the doses of the vaccine.